ARMC Recognized for Commitment to Type 2 Diabetes Treatment

Arrowhead Regional Medical Center (ARMC) has earned Participant status from the 2022 Target: Type 2 Diabetes Recognition Program in recognition of its commitment to improving its quality of diabetes care through increased awareness, detection, and management of type 2 diabetes, cardiovascular symptoms, and risk factors.

To be recognized, ARMC committed to quality improvement for its patient care related to type 2 diabetes and cardiovascular risk factors. ARMC registered with the Target: Type 2 Diabetes program and provided data pertaining to its patient population, clinical protocol and processes, and outcomes as they relate to type 2 diabetes.

Cardiovascular disease can lead to a risk of heart attacks, strokes, and disabilities for people living with diabetes. ARMC is dedicated to supporting its patient population’s total health and wellbeing, and the ARMC Comprehensive Stroke Center has aligned with Target: Type 2 Diabetes in the mission to reduce the risk of stroke in type 2 diabetes patients. This award-winning stroke center provides a high standard of stroke care that meets nationally accepted and evidence-based standards. In addition to stabilizing and treating acute stroke patients, ARMC provides support services for stroke survivors and their caregivers as well as preventive care.